Sen. Sue Rezin

Filed: 2/23/2023

 

 


 

 


 
10300SB1413sam001LRB103 28324 SPS 57793 a

1
AMENDMENT TO SENATE BILL 1413

2    AMENDMENT NO. ______. Amend Senate Bill 1413 by replacing
3everything after the enacting clause with the following:
 
4    "Section 1. Short title. This Act may be cited as the Sale
5of Pharmaceuticals on Social Media Act.
 
6    Section 5. Definition. As used in this Act:
7    "Individual" does not include a manufacturer or
8distributor identified on the label of a drug approved under
9the Federal Food, Drug, and Cosmetic Act, a biological product
10licensed under the Public Health Service Act, or a drug
11marketed in accordance with an over-the-counter monograph
12under the Federal Food, Drug, and Cosmetic Act.
13    "Social media" has the same meaning as defined in Section
146-5 of the Liquor Control Act of 1934.
 
15    Section 10. Sale of pharmaceuticals on social media;

 

 

10300SB1413sam001- 2 -LRB103 28324 SPS 57793 a

1verification process. Notwithstanding any other provision of
2law, no individual shall sell or advertise the sale of a
3pharmaceutical on social media unless the individual has
4completed the following verification process:
5        (1) the individual shall submit an image of both the
6    front and back of the individual's state-issued
7    identification card to the social media platform upon or
8    through which the pharmaceutical is to be sold or
9    advertised;
10        (2) a disclaimer must be included in any advertisement
11    for the pharmaceutical on the social media platform that
12    clearly discloses the name of the individual selling the
13    pharmaceutical;
14        (3) the individual must be identified on the social
15    media page upon which the pharmaceutical is being sold or
16    advertised; and
17        (4) the individual must display a disclaimer on the
18    individual's main page on the social media platform
19    stating that the owner or operator sells or advertises the
20    pharmaceutical on that social media platform.".